Ignite Creation Date:
2024-05-05 @ 10:47 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01184885
Status:
COMPLETED
Last Update Posted:
2017-12-18
First Post:
2010-08-17
Brief Title:
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Thomas Jefferson University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoid Malignancies New or Relapsed |
| Acute Lymphoblastic Leukemia |
| Burkitt Lymphoma |
| Lymphoblastic Lymphoma |
| Mantle Cell Lymphoma |
| Adult T-cell LeukemiaLymphoma |
Keywords:
| Name | View |
|---|---|
| adult t cell lymphoma | View |
| hyperCVAD | View |
| rapamycin | View |
| lymphoid malignancies | View |
| lymphoblastic leukemia | View |
| B and T cell | View |
| philadelphia chromosome negative | View |
| burkitt lymphoma | View |
| burkitt-type lymphoma | View |
| lymphoblastic lymphoma | View |
| mantle cell lymphoma | View |
| adult t cell leukemia | View |